Cargando…
Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer
Posterior reversible encephalopathy syndrome (PRES) is an increasingly recognizable neuro-clinical syndrome. Clinical and neurological manifestations of PRES include hypertension, headache, encephalopathy, seizures, and symmetrical white matter changes on brain MRI. Most common precipitants of PRES...
Autores principales: | Hamid, Mohsin, Ghani, Ali, Micaily, Ida, Sarwar, Usman, Lashari, Bilal, Malik, Faizan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998282/ https://www.ncbi.nlm.nih.gov/pubmed/29915651 http://dx.doi.org/10.1080/20009666.2018.1478563 |
Ejemplares similares
-
A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
por: Hamid, Mohsin, et al.
Publicado: (2018) -
Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017) -
Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020) -
Cognitive Sequelae of Central-Variant Posterior Reversible Encephalopathy Syndrome (PRES)
por: Seemiller, Joseph, et al.
Publicado: (2021) -
Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Bitar De Zayas-Enriquez, A., et al.
Publicado: (2019)